mrx0518 pembro in patients with resistance to therapy
Published 4 years ago • 507 plays • Length 8:04Download video MP4
Download video MP3
Similar videos
-
7:32
updates on mrx0518 pembro in patients with resistance to therapy
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
1:38
future indications for mrx0518
-
1:12
reactivating antitumor efficacy of anti-pd-1 therapy with mrx0518
-
1:31
mrx0518 combination therapy meets primary efficacy endpoint ahead of enrollment completion
-
1:53
mrx0518 modification of solid tumor microenvironment
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
2:23
strategies to improve time to diagnosis in patients with cancer
-
0:54
surpass: adp-a2m4cd8 t-cell receptor t-cell therapy and pembrolizumab in uc
-
1:17
prince: 177lu-psma-617 and pembrolizumab in prostate cancer
-
1:21
keynote-921: pembrolizumab plus docetaxel in chemotherapy-naïve mcrpc
-
2:06
sakk 08/16: darolutamide maintenance therapy for previously treated patients with mcrpc
-
6:17
pcrt16-001: can pegph2o remodel the stroma to sensitize patients with ha-high pc to immunotherapy?
-
1:19
pemrec: neo-adjuvant pembrolizumab and rt in rectal cancer
-
3:58
prognosis & advances in treatment strategies for sf3b1-mutant mds